Will the FDA approve baxdrostat for hard-to-control hypertension? Odds & Analysis

KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★ KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★ KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★ KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★ KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★ KXFDAAPPROVE-BAX ★ KALSHI ★ MULTI ★

← Back

Will the FDA approve baxdrostat for hard-to-control hypertension?

Market price history

Rolling 7-day window of market YES price with the OU fair-price range overlay.

Not enough history yet for a chart.
New points land on each refresh — check back shortly.

Market price

Before Jan 1, 202794¢

Before Sep 1, 202693¢

Before Jul 1, 2026★ BEST93¢

Before Aug 1, 202693¢

Kalshi • Volume: 2.1K contracts • Updated 22d agoCloses: 2027-01-01

Settled

Winner: Before Jan 1, 2027. Live analysis is no longer available. Last data from May 18, 2026.

View on Kalshi↗

Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.